Projects per year
Personal profile
Biography
Jandeleit-Dahm research group: www.med.monash.edu/cecs/diabetes/research/jandeleit-dahm-group.html
Keywords
- Diabetes
- Diabetic complications
- diabetic nephropathy
- cardiovascular disease
- oxidative stress
- reactive oxygen species
- unstable plaque
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2021
- 5 Active
Targeting epigenetic pathways that lead to diabetic complications
Cooper, M. E., El-Osta, A., Jandeleit-Dahm, K. & Quaggin, S.
1/01/18 → 31/12/21
Project: Research
Nox5 as a potential biomarker for cardiovascular disease including in diabetes
Jandeleit-Dahm, K. & Shaw, J. A.
1/01/17 → 31/12/18
Project: Research
RAGE and ACE2 shedding as therapeutic targets in diabetes and cardiovascular disease
Thomas, M. C., Jandeleit-Dahm, K., Wilton, S. D. & Tikellis, C.
1/01/17 → 31/12/19
Project: Research
JDRF/NHMRC Diabetes Complications Centre of Research Excellence
Cooper, M. E., Thomas, M. C., El-Osta, A., Jandeleit-Dahm, K., Groop, P., Bach, L. A. & Wilkinson-Berka, J.
1/12/14 → 30/11/19
Project: Research
Research Output 2004 2018
Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease
Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R., Tan, S. M., Tasadaque Ali-Shah, S., Guiry, P. J., El-Osta, A., Jandeleit-Dahm, K., Cooper, M. E., Godson, C. & Kantharidis, P. 1 May 2018 In : Journal of the American Society of Nephrology. 29, 5, p. 1437-1448 12 p.Research output: Contribution to journal › Article › Research › peer-review
Metabolic karma-the atherogenic legacy of diabetes: The 2017 edwin bierman award lecture
Cooper, M. E., El-Osta, A., Allen, T. J., Watson, A. M. D., Thomas, M. C. & Jandeleit-Dahm, K. 1 May 2018 In : Diabetes. 67, 5, p. 785-790 6 p.Research output: Contribution to journal › Article › Other
SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus
Gill, A., Gray, S., Jandeleit-Dahm, K. & Watson, A. M. D. 17 Apr 2018 (Accepted/In press) In : Current Diabetes Reviews.Research output: Contribution to journal › Review Article › Other › peer-review
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease
Gray, S. P., Jha, J. C., Kennedy, K., Bommel, E. V., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E. & Jandeleit-Dahm, K. A. M. May 2017 In : Diabetologia. 60, 5, p. 927-937 11 p.Research output: Contribution to journal › Article › Research › peer-review
GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes
Ying, Y. L., Chen, Y. C., Jandeleit-Dahm, K. & Peter, K. 1 Oct 2017 In : Atherosclerosis. 265, p. 250-252 3 p.Research output: Contribution to journal › Editorial › Other › peer-review